Breakthrough Rhizopus spp. in an immunocompromised patient receiving caspofungin. Case Report and review  by Dunkel, N. et al.
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Recurrent vulvovaginal candidiasis- where does Candida
albicans persist?
F. Beikert ∗, M.T. Le, A. Clad
University of Freiburg, Freiburg, Germany
Background: 5-8% of all women of childbearing age suf-
fer from recurrent vulvovaginal candidiasis (RVVC). In most
cases, recurrences are caused by identical Candida strains
suggesting a site of C. albicans persistence in female geni-
talia. The purpose of this study was (1) to investigate where
C. albicans persists despite prolonged oral therapy, (2) to
determine the clinical symptoms and signs related to C.
albicans positive vulvar cultures and (3) to evaluate a new
therapeutic approach in women with positive interlabial cul-
tures.
Methods: A total of 469 women with recurrent vul-
vovaginal complaints were examined by colposcopy and
microscopy of vaginal smears was performed. Swabs were
obtained from both vagina and interlabial sulcus of the
external vulva and cultured for fungal growth. Women
with positive C. albicans cultures from the external vulva
received 100mg of oral ﬂuconazole daily for 20 days and top-
ical ciclopiroxolamin cream applied in the interlabial sulcus
and perianally for 4 weeks. Follow-up visits were at 3, 6, 9
and 12 months.
Results: Of 469 women with chronic vulvovaginal com-
plaints, 139 patients (30%) had positive C. albicans cultures.
Of these 139 patients, 70% had both C. albicans positive vul-
var and vaginal cultures, 24% had positive cultures from the
vagina only and 6% from the interlabial sulcus only. Pruri-
tus (OR 5.4; 95% CI 2.0 - 14.9), signs of vulvar edema (OR
3,8; 95%CI 1.0-16.8) and ﬁssures (OR 2.4; 95%CI 1.0-5.8)
correlated with positive vulvar cultures.
Recurrence rates for the combined treatment were 27%
at 6 months and 34% at 12 months.
Conclusion: Our results point at the stratum corneum of
the moist interlabial sulcus rather than the non-keratinizing
vaginal epithelium as the site of C. albicans persistence and
source of endogenous re-infection in patients with recur-
rent vulvovaginal candidiasis. Based on this hypothesis and
analogous with the treatment of nail mycosis, we used a
combination of the fungistatic ﬂuconazole and fungicidal
ciclopiroxolamin cream. This new approach showed promis-
ing results.
doi:10.1016/j.ijid.2010.02.1752
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Delayed diagnosis of disseminated Histoplasmosis cap-
sulatum var. capsulatum infection in AIDS patients in a
tuberculosis high endemic country
P. soentjens1,∗, I. Eshun-Wilson2, J. Taljaard3
1 Military Hospital Brussels, Brussels, Belgium
2 Tygerberg Academic Hospital, CapeTown, South Africa
3 Tygerberg academic Hospital, Cape Town, South Africa
Background: Histoplasmosis is an low endemic myco-
sis in some parts of South Africa. The ﬁnal diagnosis of
disseminated histoplasmosis (DH) requires pathology and
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icrobiology. Diagnosis and effective treatment is often
elayed in resource-constrained settings, because clinical
eatures could be confused with disseminated tuberculosis,
nd specialized services are limited. To our knowledge, this
s the ﬁrst reported case series of HIV infected patients with
H in Africa.
Methods: We report retrospective descriptive data on a
eries of HIV and DH co-infected patients attending an aca-
emic hospital between September 2003 and December 2008
n the Western Cape region.
Clinical and laboratory characteristics of all diagnosed
H were analysed with the statistical package SPSS 15.0.
Results: During the study period, 11 cases of DH were
iagnosed: the majority of cases occurred in men (82%).
All DH patients presented with skin lesions in addi-
ion to other symptoms of which 6 had fever (55%), 9
ad constitutional symptoms (weakness, night sweats and
eight loss) (82%), 6 had epistaxis (55%), 5 had respira-
ory symptoms (45%), and 4 had gastrointestinal complaints
36%).
The mean CD4 lymphocyte count was 43 cells/l (IQR:
-107). The mean CRP level was 166 mg/dl (IQR: 27-306),
he LDH was 887 U/l (IQR: 158-3220). Pancytopenia was
iagnosed in 3 patients.
Diagnosis was made in all patients by positive
istopathology results (100%); only 3 patients had a micro-
iologically conﬁrmed culture result (27%). The mean
ime-interval between ﬁrst symptoms and treatment was
48 days (IQR: 80-305).
Three patients developed paradoxical IRIS features
27%) and three patients unmasking DH after initiation of
ntiretroviral treatment (ART) (27%). One patient died of
H (9%), due to delayed diagnosis and treatment, after two
ays of intravenous amphotericin.
Conclusion: In a tuberculosis high endemic region, where
any AIDS patients with a very low CD4 count are seen in
ntiretroviral clinics, the follow-up of patients is complex,
ostly due to TB related infections.
A high index of suspicion for DH is necessary to detect
peciﬁc clinical characteristics on time. Patients who
resent with constitutional symptoms and skin lesions should
e checked for DH through pathology and/or microbiology. A
resenting epistaxis, and a relative high CRP should increase
he likelihood of the diagnosis of DH.
oi:10.1016/j.ijid.2010.02.1753
0.013
reakthrough Rhizopus spp. in an immunocompromised
atient receiving caspofungin. Case Report and review
. Dunkel ∗, J. Ambrosioni, Y. Chalandon, J. Passweg, J.
arbino
University Hospital of Geneva, Geneva, Switzerland
Background: Invasive zygomycosis is a rare opportunis-
ic fungal disease, with high morbidity and mortality rates
hat affects predominantly immunosuppressed patients. An
ncrease incidence is observed with the widespread use of
ewer antifungal drugs, such as voriconazol and caspofun-
in. We report a case of breakthrough invasive zygomycosis
n a stem cell transplant recipient on sequential voricona-
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ole and caspofungin treatment, and we review the previous
ublished cases.
Methods: Analysis of a clinical case with zygomycosis
reakthrough infection and review of previous published
ases.
Results: To date, seven cases of immunocompromised
atient with breakthrough zygomycosis infection receiving
aspofungin were published (Table 1)
In September 2007, a 51 year old female patient was
dmitted for myelodysplastic syndrome RAEB-T, diagnosed
year before. A related allogenic hematopoietic stem cells
ransplant (HSCT) (HLA 9/10) was performed. On October
2th, the patient developed an hepatic GVHD, treated by
rednisone. The clinical evolution was good and the patient
as discharged of the hospital on October 29th on pred-
isone, cyclosporine, penicillin V, valaciclovir, voriconazole,
o-trimoxazole and folinic acid. These treatments were
topped 6 weeks later.
On January 3rd, the patient was readmitted presenting a
ebrile state and aqueous diarrhea.
An acute digestive GVHD was diagnosed and large spec-
rum antimicrobial treatment was initiated. Voriconazole
as switched to caspofungin on January 16th, due to liver
ests enzymes alteration
After 1 week of treatment, a thoracic CT scan was per-
ormed and revealed signs of pulmonary infection. Nasal
wab and bronchoalveolar lavage cultures grew with Rhi-
opus spp. The patient experienced an important clinical
orsening. Considering the severity of infectious and hema-
ologic prognosis as well as the lack of clinical response, the
hysician according with the family decided to stop aggres-
ive therapy. The patients died 10 days later.
The autopsy ﬁnding showed that the death was due to a
isseminated angioinvasive mycotic infection.
Conclusion: As reported with voriconazole, prolonged
aspofungin treatment may be a risk factor for invasive
ygomycosis infection in immunocompromised patients. This
isease must be always considered in immunocompromised
atient receiving caspofungin therapy.
oi:10.1016/j.ijid.2010.02.1754
0.014
ranulomatous lesions in experimental Paracoccidioides
rasiliensis infection
. Burger1,∗, R.F.S. Molina2, J.V. Alves2, C.R.P. Pizzo2, A.S.
ishikaku2
Universidade Federal do Espirito Santo; Universidade de
ao Paulo, Sao Mateus e Sao Paulo, Espirito Santo e Sao
aulo, Brazil
Universidade de São Paulo, Sao Paulo, Sao Paulo, Brazil
Background: Paracoccidioidomycosis (PCM) is a systemic
ycosis, caused by the fungus Paracoccidioides brasiliensis
Pb), that affects healthy individuals living in rural areas in
atin America. There are many clinical forms of the disease;
evere forms are characterized by the presence of numer-
us disseminated granulomatous lesions, anergy in cellular
mmunity and high levels of speciﬁc antibodies, in con-
rast, mild forms have few localized granulomatous lesions,
reserved cellular immunity and low levels of speciﬁc anti-
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odies. Granuloma formation can be interpreted as a host
efense mechanism to destroy or contain Pb and avoid its
issemination.
Methods: We infected susceptible (S) and resistant
R) mice with Pb to study the granulomas. We analysed
he architecture of the granulomas and associated with
resence of morphologically preserved or destroyed Pb,
eposition of some extracellular matrix (ECM) components
collagen ﬁbers types I, II, IV, osteopontin, laminin, bigly-
an, decorin), presence of relevant cytokines to granuloma
ormation (/-IFN, TGF-$, TNF-&) and of matrix metallopro-
einases (MMP).
Results: We detected all the above mentioned elements
n the lesions. The thick ﬁbers of collagen type I, (R > S)
ay be associated with Pb infection containment; the thin
eticular ﬁbers of collagen type III may promote themicroen-
ironment for Pb-cell-ECM interactions; the marker of newly
ormed vessels collagen type IV may promote Pb dissemi-
ation and favor the inﬂux of inﬂammatory cells and the
roteoglycans biglycan and decorin, (R > S) may promote
ungal containment. The cytokines TNF-& and /-IFN, this
ater more observed in R mice may promote macrophage
ctivation, enhancing Pb killing by these cells and the
ontrol fungal dissemination; TGF-$, (S > R) may promote
eactivation and inhibition of Pb killing by macrophages,
avoring fungal dissemination and osteopontin may favor
nfection at its onset (S > R) and promote protection later
R > S). MMP-9 was detected in both S and R mice with active
nfection, eventually being involved in fungal dissemination.
Conclusion: The fate of PCM infection locally depends
f the combined effects of ECM components, which can be
imiting or permissive to Pb dissemination, and those of
ytokines, which can either activate or inactivate phago-
ytic cells, leading to Pb lysis or survival.
oi:10.1016/j.ijid.2010.02.1755
0.015
ibrosis treatment in experimental Paracoccidioides
rasiliensis infection
. Burger1,∗, A.S. Nishikaku2, J.V. Alves2, C.R.P. Pizzo2,
.F.S. Molina2
Universidade Federal do Espirito Santo and Universidade
e Sao Paulo, Sao Mateus and Sao Paulo, Espirito Santo and
ao Paulo, Brazil
Universidade de São Paulo, Sao Paulo, Sao Paulo, Brazil
Background: Paracoccidioidomycosis (PCM) is a deep
ycosis that presents frequent and incapacitating sequelae
ue to the development of numerous ﬁbrotic granulomatous
esions even after mycological cure, rendering the quality of
ife of the patients extremely poor.
After characterization of the granulomas developed by
usceptible (S) and resistant (R) mice infected Paracoccid-
oides brasiliensis (Pb), we evaluated the effect of drugs
hat interfere with ﬁbrosis. We treated S mice with drugs
hat interfere with ﬁbrosis: we used the cytokine -IFN
ecause, in addition to its known effect as macrophage acti-
ator, it presents direct antiﬁbrotic activity; Tetracycline
ue to its inhibitory effect on extracellular matrix (ECM) syn-
hesis in addition to its antibacterial effect and the speciﬁc
